- Home
- ARTW vs GTBP Comparison
ARTW vs GTBP Comparison
Compare ARTW & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARTW | GTBP |
|---|---|---|
| Founded | 1956 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 12.1M |
| IPO Year | 1996 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ARTW | GTBP |
|---|---|---|
| Price | $2.21 | $0.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 47.9K | ★ 653.6K |
| Earning Date | 02-19-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 233.33 | 3.75 |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $22,975,408.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.43 | $0.39 |
| 52 Week High | $4.69 | $3.73 |
Technical Indicators
Market Signals| Indicator | ARTW | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 44.03 |
| Support Level | $2.11 | $0.40 |
| Resistance Level | $2.49 | $0.59 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 18.29 | 52.22 |
Price Performance
Historical ComparisonAbout ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.